Psoriasis and atherothrombotic diseases: disease-specific and non-disease-specific risk factors.

Paolo Gisondi, Giampiero Girolomoni · Seminars in Thrombosis and Hemostasis · 2009

Summary

Patients with psoriasis should be treated effectively and encouraged to aggressively correct their modifiable cardiovascular risk factors, particularly cardio-metabolic comorbidities.

Type: review
Published: 2009-04-01
Cited by: 103
References: 0
DOI: https://doi.org/10.1055/s-0029-1222610
PubMed: https://pubmed.ncbi.nlm.nih.gov/19452407/
OpenAlex: https://openalex.org/W1973563124
Semantic Scholar: https://api.semanticscholar.org/CorpusID:31816925

Keywords

Psoriasis, Disease, Medicine, Dermatology, Internal medicine

References

No references recorded for this paper.

Cited by

Framingham Risk Score underestimates cardiovascular disease risk in severe psoriatic patients: Implications in cardiovascular risk factors management and primary prevention of cardiovascular diseaseMichel Couderchet, Brigitte Brozio, Peter Böger — 2013
[Psoriasis and cardiovascular disease].Tiago Torres, Rita Sales, Carla Maria Lins de Vasconcelos — 2013
Cardiovascular risk factors in patients with chronic plaque psoriasis: a case-control study on the Brasov County population.Marius Irimie, A Oanţă, Claudia Alexandrina Irimie — 2015
Association of endothelial nitric oxide synthase Glu298Asp gene polymorphism in psoriasis cases with hypertensionZerrin Öğretmen, Meliha Merve Hız, Fatma Sılan — 2014
Central retinal vein occlusion following infliximab treatment for plaque‐type psoriasisTheognosia Vergou, Aikaterini E. Moustou, Apostolos Maniateas — 2010
Avaliação da resposta imune anti-Mycobacterium tuberculosis em pacientes com psoríase moderada a grave submetidos à terapia com inibidor de fator de necrose tumoral, infliximabeLuciena Cegatto Martins Ortigosa — 2014
C-Reactive Protein and Markers for Thrombophilia in Patients with Chronic Plaque PsoriasisPaolo Gisondi, Mario Malerba, Giovanna Malara — 2010
Psoriasis and extra domain A fibronectin loopsJohn Mcfadden, Barbara S. Baker, A.V. Powles — 2010
Metabolic abnormalities associated with initiation of systemic treatment for psoriasis: evidence from the Italian Psocare RegistryPaolo Gisondi, Simone Cazzaniga, Sergio Chimenti — 2013
Lack of association between leptin, leptin receptor, adiponectin gene polymorphisms and epicardial adipose tissue, abdominal visceral fat volume and atherosclerotic burden in psoriasis patientsTiago Torres, Nuno Bettencourt, Joana Ferreira — 2015
Psoriasis: rationale for targeting interleukin‐17Giampiero Girolomoni, Ulrich Mrowietz, C. Paul — 2012
The Cost Effectiveness of Biologic Therapy for the Treatment of Chronic Plaque Psoriasis in Real Practice Settings in ItalyFederico Spandonaro, Fabio Ayala, Enzo Berardesca — 2014
Drug-Induced Acute Myocardial Infarction: Identifying ‘Prime Suspects’ from Electronic Healthcare Records-Based Surveillance SystemPreciosa M. Coloma, Martijn J. Schuemie, Gianluca Trifirò — 2013
Cardiometabolic comorbidities and the approach to patients with psoriasis.Paolo Gisondi, Giampiero Girolomoni — 2009
Quantifying cardiovascular disease risk factors in patients with psoriasis: a meta‐analysisI.M. Miller, Tea Skaaby, Christina Ellervik — 2013
Meta-analysis of psoriasis, cardiovascular disease, and associated risk factors.I.M. Miller, Christina Ellervik, Shiva Yazdanyar — 2013
Portal vein thrombosis associated with psoriasis: a case reportJevon Yudhishdran, Rayno Navinan, Sivakumar Jeyalakshmy — 2015
Metabolic and Cardiovascular Comorbidities in Psoriasis: RevisitedKH Basavaraj — 2015
Psoriasis and Hypertension Severity: Results from a Case-Control StudyApril W. Armstrong, Steven W. Lin, Cynthia J. Chambers — 2011
The prevalence of metabolic syndrome in patients with hidradenitis suppurativa.Daniel Gold, Virginia J Reeder, Meredith G. Mahan — 2014

Psoriasis and atherothrombotic diseases: disease-specific and non-disease-specific risk factors.

Summary

Keywords

References

Cited by

Related papers